Increased colon transit time and faecal load in irritable bowel syndrome

被引:0
|
作者
Dennis Raahave [1 ]
Andreas K Jensen [2 ]
机构
[1] Department of Gastroenterology and Surgery, Copenhagen University North Sealand Hospital
[2] Faculty of Health Sciences, Section of Biostatistics, University of Copenhagen
关键词
D O I
暂无
中图分类号
R574.4 [肠道功能紊乱];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Irritable bowel syndrome(IBS) is a bowel disorder involving abdominal pain or discomfort along with irregularity of stool form and passage frequency. The pathophysiology is poorly understood and seems to be multifactorial. Investigations of possible causes of IBS have included only a few colonic transit studies and no simultaneous determination of the colonic faecal content.AIM To compare colon transit time and faecal load between IBS-patients and healthy control subjects.METHODS The study included 140 patients with IBS, with a mean age of 50.0 years. The control group comprised 44 healthy persons with a mean age of 43.4 years, who were selected at random from the National Civil Register. Both the patient group and the control group underwent a marker study to measure colon transit time(CTT) and to calculate a faecal loading score. The patient group underwent treatment with a combined prokinetic regime, after which their CTT and faecal loading were reassessed. Analyses were performed to compare measurements between the control group and the patient group before and after treatment.RESULTS Compared to healthy controls, IBS-patients exhibited a significantly prolonged mean CTT(45.48 h vs 24.75 h, P = 0.0002) and significantly greater mean faecal loading scores in all colonic segments(P < 0.001). Among IBS patients, we found no significant differences between the 48 h and 96 h radiographs. Among patients exhibiting increased CTT and faecal loading, approximately half exhibited apalpable mass in the right iliac fossa. After intervention with a prokinetic treatment, the mean CTT among IBS patients was reduced from 45.48 h to 34.50 h(P = 0.091), with the post-treatment CTT not significantly differing from the CTT among control subjects(P = 0.095). The faecal loading score among IBS patients did not significantly differ before and after treatment(P = 0.442). The posttreatment faecal loading score in IBS patients remained significantly higher compared to that in controls(5.3 vs 4.3, P = 0.014). After treatment, half of the IBSpatients were relieved of bloating, while the majority no longer experienced abdominal pain and achieved a daily consistent stool.CONCLUSION IBS-patients exhibited prolonged CTT and heavier faecal loading. These assessments may aid in diagnosis. Faecal retention may contribute to IBS symptoms, which can be treated using a prokinetic regime.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [21] Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
    Daebritz, Jan
    Musci, Jason
    Foell, Dirk
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (02) : 363 - 375
  • [22] Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
    Jan Dbritz
    Jason Musci
    Dirk Foell
    World Journal of Gastroenterology, 2014, 20 (02) : 363 - 375
  • [23] DOES IRRITABLE BOWEL SYNDROME SMELL DIFFERENT FROM IRRITABLE BOWEL DISEASE? A STUDY OF FAECAL VOLATILE ANALYSIS IN INFLAMMATORY BOWEL SYNDROME
    Ahmed, I.
    Greenwood, R.
    Probert, C. S.
    GUT, 2010, 59 : A2 - A2
  • [24] Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
    Emmanuel, Anton
    Landis, Darryl
    Peucker, Mark
    Hungin, A. Pali S.
    FRONTLINE GASTROENTEROLOGY, 2016, 7 (04) : 275 - 282
  • [25] Stool characteristics and colonic transit in irritable bowel syndrome: evaluation at two time points
    Shim, Lisa
    Talley, Nicholas J.
    Boyce, Philip
    Tennant, Chris
    Jones, Mike
    Kellow, John E.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (03) : 295 - 301
  • [26] Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome
    Thumshirn, M
    Coulie, B
    Camilleri, M
    Zinsmeister, AR
    Burton, DD
    Van Dyke, C
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (07) : 869 - 878
  • [27] THE SCINTIGRAPHIC DETERMINATION OF SMALL INTESTINAL TRANSIT-TIME IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
    MARANO, AR
    CARIDE, VJ
    SHAH, RV
    PROKOP, EK
    TRONCALE, FJ
    MCCALLUM, RW
    JOURNAL OF NUCLEAR MEDICINE, 1984, 25 (05) : P59 - P60
  • [28] EFFECTS OF CIMETROPIUM BROMIDE ON GASTROINTESTINAL TRANSIT-TIME IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
    PASSARETTI, S
    GUSLANDI, M
    IMBIMBO, BP
    DANIOTTI, S
    TITTOBELLO, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1989, 3 (03) : 267 - 276
  • [29] Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
    Wong, B. S.
    Camilleri, M.
    Eckert, D.
    Carlson, P.
    Ryks, M.
    Burton, D.
    Zinsmeister, A. R.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (04):
  • [30] Increased mast cells in the irritable bowel syndrome
    O'Sullivan, M
    Clayton, N
    Breslin, NP
    Harman, I
    Bountra, C
    McLaren, A
    O'Morain, CA
    NEUROGASTROENTEROLOGY AND MOTILITY, 2000, 12 (05): : 449 - 457